Johoku-Cilnidipine trial of renal function, uric acid and blood pressure for clinical evaluation 2

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: Cilnidipine group L‐type CCB group CONDITION: Hypertension PRIMARY OUTCOME: Changes in serum uric acid and urinary uric acid SECONDARY OUTCOME: 1. Clinic blood pressure; 2. Urinary albumin / creatinine ratio; 3. Fractional excretion of uric acid INCLUSION CRITERIA: Hypertensive patients with serum uric acid > 6.0 mg/dL under ARB administration more than three months
Epistemonikos ID: c3c8e1b844addb900ac143badffa7d270b51866d
First added on: Aug 22, 2024